Randall-Type Monoclonal Immunoglobulin Deposition Disease in Bone Scintigraphy

Clin Nucl Med. 2023 Dec 1;48(12):e611-e613. doi: 10.1097/RLU.0000000000004927. Epub 2023 Oct 23.

Abstract

Bone scintigraphy is recognized as a noninvasive alternative to endomyocardial biopsy for the diagnostic of wild-type (wATTR) and hereditary ATTR amyloidosis (hATTR). Light chain amyloidosis (AL), Randall-type monoclonal immunoglobulin deposition disease , sarcoidosis, hemochromatosis, Fabry disease, and mucopolysaccharidoses are differential diagnosis of ATTR amyloidosis. Bone scintigraphy allows visualization of extracardiac involvements of AL amyloidosis: pleural, retroperitoneal, liver, spleen, and soft tissue. We report the case of a patient who underwent bone scintigraphy for suspected ATTR amyloidosis. Bone scan showed cardiac (Perugini score 2), hepatic, and renal hyperfixation. A cardiac biopsy demonstrated a Randall-type deposit, without amyloid deposit.

Publication types

  • Case Reports

MeSH terms

  • Amyloidosis* / diagnostic imaging
  • Cardiomyopathies*
  • Heart Diseases*
  • Humans
  • Immunoglobulins
  • Multiple Myeloma*
  • Radionuclide Imaging
  • Tomography, X-Ray Computed

Substances

  • Immunoglobulins